Clinical and biologic features of CD4+CD56+ malignancies - Wikidata - wikimedia - TriplyDB

Clinical and biologic features of CD4+CD56+ malignancies

Clinical and biologic features of CD4+CD56+ malignancies

http://www.wikidata.org/entity/Q57693402

about

Extramedullary Manifestations of Myeloid Neoplasms Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.Blastic plasmacytoid dendritic cell leukemia successfully treated by autologous hematopoietic stem cell transplantation to a remission of 48-month duration Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia.Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.CD4+ CD56+ neoplasia: clinical and biological features with emphasis on cytotoxic drug-induced apoptosis and expression of sialyl Lewis X.What is CD4+CD56+ malignancy and how should it be treated?Immunophenotyping of acute leukemias and myelodysplastic syndromes.Good clinical response in a rare aggressive hematopoietic neoplasm: plasmacytoid dendritic cell leukemia with no cutaneous lesions responding to 4 donor lymphocyte infusions following transplant.Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?State of the art in myeloid sarcoma.Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review.Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature.Cutaneous blastic plasmacytoid dendritic cell neoplasm occurring after spontaneous remission of acute myeloid leukemia: a case report and review of literature.Blastic plasmacytoid dendritic cell neoplasm: a single-center experience.Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: a case report and review of literature.Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.Transplantation in rare lymphoproliferative and histiocytic disorders.Clinicopathological analysis of 46 cases with CD4+ and/or CD56+ immature hematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and -related neoplasms.Neoplasms derived from plasmacytoid dendritic cells.Selective apoptosis of natural killer-cell tumours by l-asparaginase.G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy.Blastic plasmacytoid dendritic cell neoplasm with extensive cutaneous and central nervous system involvement.Blastic plasmacytoid dendritic cell neoplasm.CD4+ CD56+ Hematodermic Neoplasm Without Cutaneous Involvement.MHC class II signaling function is regulated during maturation of plasmacytoid dendritic cells.TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.A case of blastic plasmacytoid dendritic cell neoplasm: cytomorphological findings of the touch imprint specimen of lymph node.Case study interpretation-New Orleans: case 5. Blastic plasmacytoid dendritic cell neoplasm.Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.CLTC-ALK fusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm.Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.Differentiation of follicular dendritic sarcoma cells into functional myeloid-dendritic cell-like elements.Splenic Rupture Secondary to Blastic Plasmacytoid Dendritic Cell Neoplasm.Complete monocular vision loss due to optic nerve involvement of blastic plasmacytoid dendritic cell neoplasm.Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia.

P2860

Q26799783-19767F16-72F1-4D3A-87DC-855BB65722BA Q30249813-2D023368-C227-4AD4-BDAC-8975AFE90E27 Q33412503-BE0F0251-2DE6-4FC9-A13D-D97562A4F905 Q34096751-23EC9C48-CC12-4CCF-AF16-A09B818AFBBA Q34955908-0C5F0A04-1E17-470B-BF98-BA9A227B35DF Q35104381-80024118-C5F4-45C6-B353-38D5F670B2B6 Q35226503-695A53FF-6283-472B-9694-A6EDED2DADF2 Q35679885-476F88D2-921C-42A4-9379-AAF473BD1318 Q36417590-B8496322-D3C3-4020-B92A-79AD267572F3 Q36455996-10DC7086-2A0E-4348-B855-9F61C46399D5 Q36762575-7439F6A5-F63D-4500-9219-CA4E2C5372A2 Q37924991-BA573A84-78D2-4AB2-B0DA-195D2459871A Q37975056-0CD60427-FC71-460B-9571-F96128129CB7 Q37997833-5A968DC3-92BD-448F-A6EC-7ED221F0F340 Q38000073-3951E4D2-78B4-41C9-BF5C-770FA7572F43 Q38058425-5C97AB5D-A21E-4727-ABE8-BB1653E922D6 Q38115993-D75F3F4E-50B2-4C3A-B644-7BDF18DB1A22 Q38213642-69F7BE94-4F53-4037-A7CE-B328A56F3DD6 Q38259612-D85F3C99-0840-4B30-8B87-7E96FF2BFBC4 Q38259618-2A323B36-8D6D-4043-A9D9-4D6065FBE2A9 Q38631079-5723C012-4E14-4DF8-8413-824340683373 Q38689894-EB0BD089-0CD6-43E7-8447-DDA41209F730 Q40374756-E36F0D93-7CD2-49D3-A6D1-0F6007669D61 Q40519407-5E2A4FD4-D66F-4701-96B3-947E09E65677 Q41087617-04354F2A-27FD-4015-B996-D731F0DD3DA6 Q41789755-A581F93F-2671-425B-8152-C384C8CF6837 Q42769708-117A600C-0A88-4B5F-9C89-64F732BC2AED Q42938613-DA2404A2-90FA-4BBC-B0F4-DFE6A267D0B4 Q44224972-367708D1-B44B-4009-A678-6BB12CF070EB Q44288796-B32C7386-2BCF-4099-892B-2B7056E3F629 Q44324082-BEDCE20E-52B7-4272-B735-61DD277510BF Q44936393-7A49F3E2-2B05-4F08-9546-247DAAEFCC89 Q46118251-7F68A325-45C0-4899-9CF9-27F1230D003E Q46465423-26AF5E41-4B87-4F5D-8841-1C6BFCFC2C80 Q47567814-0B61D24F-D007-403A-93A6-FAC66AC9268E Q47975636-209E646D-0854-4FAB-8757-39E08B2C991D Q48266045-7ECB67CC-82CE-4F48-9ABC-DE238368C100 Q49583935-8635D70C-131D-4A64-89A1-67F362A6150B Q52040021-25A6A24F-7EDC-4A78-A1A7-509FCEB0A5D9 Q52859434-9AA2DEE5-649A-43F1-B79E-5089B0BD2813

P2860

Clinical and biologic features of CD4+CD56+ malignancies

http://www.wikidata.org/entity/Q57693402

description

im März 2002 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 March 2002

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 2002

@uk

name

Clinical and biologic features of CD4+CD56+ malignancies

@en

Clinical and biologic features of CD4+CD56+ malignancies

@nl

type

label

Clinical and biologic features of CD4+CD56+ malignancies

@en

Clinical and biologic features of CD4+CD56+ malignancies

@nl

prefLabel

Clinical and biologic features of CD4+CD56+ malignancies

@en

Clinical and biologic features of CD4+CD56+ malignancies

@nl

P1433

Q57693402-26E14D0E-A637-40B8-841D-34986A2019AE

P1476

Q57693402-3D3299B7-2138-4544-83CF-A7F54A9A9266

P2093

Q57693402-0E787F04-7E00-4CB7-AC33-863758C46C09

Q57693402-3086743A-17D7-4F49-90A3-1A315F29E8B0

Q57693402-4162B5CD-913B-47CF-A441-441DBAEEA7FC

Q57693402-4D9386A8-CDBA-4A4A-8954-277FA3570AED

Q57693402-5432F829-95DC-4B7C-937A-4FF161450E1B

Q57693402-56BD523E-9EA1-494B-A346-F348EAD1E33F

Q57693402-63A94ACE-9485-42EE-AC66-06768B7DDEAC

Q57693402-697A4BF3-878C-4FD2-AC65-DAB9DCD361FD

Q57693402-6A9518EC-E090-4B76-953F-84156B80359D

Q57693402-89B7C680-F731-4CF4-A8C5-3620FB9C552F

P304

Q57693402-1E9AD354-D2FE-441A-BDC9-1286B6AA3C00

P31

Q57693402-1E18CACF-7925-4AC1-BF3C-3731312C4302

P356

Q57693402-C4D4A709-6886-4DE1-B127-4E89FC4E4D37

P407

Q57693402-8F5DF4B5-C398-4398-9B5B-ACC3D8FF8495

P433

Q57693402-02567E97-04AC-4468-8D82-BE0BEF69E4A3

P478

Q57693402-916B7F7B-5CD2-458B-A20B-A21E10F0A2D6

P50

Q57693402-0A09F9A8-E80E-4940-8F2A-95A78D052A74

Q57693402-26F1B572-FB7E-4A22-B9E4-C89948D756F7

Q57693402-2FA346B2-6622-4298-BF17-1A8FE85CF512

Q57693402-96DEEC81-3867-4841-A3A8-B01093D907BD

P577

Q57693402-F7FE8B17-0593-4D94-8653-D1DAB5AAF488

P698

Q57693402-0E27A550-6524-4BBD-97A3-B9509F929075

P356

BLOOD.V99.5.1556

P1433

P1476

Clinical and biologic features of CD4(+)CD56(+) malignancies

@en

P2093

Annie Falkenrodt

http://www.w3.org/2001/XMLSchema#string

Bernard Drénou

http://www.w3.org/2001/XMLSchema#string

Bernard Husson

http://www.w3.org/2001/XMLSchema#string

Christine Arnoulet

http://www.w3.org/2001/XMLSchema#string

Danielle Sainty

http://www.w3.org/2001/XMLSchema#string

Eliane Duchayne

http://www.w3.org/2001/XMLSchema#string

Emanuelle Homolle

http://www.w3.org/2001/XMLSchema#string

Emilienne Kuhlein

http://www.w3.org/2001/XMLSchema#string

Franck Trimoreau

http://www.w3.org/2001/XMLSchema#string

Françoise Valensi

http://www.w3.org/2001/XMLSchema#string

P304

1556-1563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD.V99.5.1556

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

FRANCOISE BRIGNOLE-BAUDOUIN

Laurence Chaperot

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11861268

http://www.w3.org/2001/XMLSchema#string